Budamagunta, Vivekananda
University of Florida
4 papers on CoChat
Most cited papers
- Verified
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
He, Y., Zhang, X., Chang, J., Kim, H.-N., Zhang, P., Wang, Y., Khan, S., Liu, X., Zhang, X., Lv, D., et al. (2020) · Nature Communications
Protein Degradation and InhibitorsTelomeres, Telomerase, and Senescence
Cited by 280
- Verified
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas
He, Y., Koch, R., Budamagunta, V., Zhang, P., Zhang, X., Khan, S., Thummuri, D., Ortiz, Y. T., Zhang, X., Lv, D., et al. (2020) · Journal of Hematology & Oncology
Protein Degradation and InhibitorsCell death mechanisms and regulation
Cited by 139
- Verified
Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines
Zhang, X., He, Y., Zhang, P., Budamagunta, V., Lv, D., Thummuri, D., Yang, Y., Pei, J., Yuan, Y., Zhou, D., et al. (2020) · European Journal of Medicinal Chemistry
Protein Degradation and InhibitorsCell death mechanisms and regulation
Cited by 71
- Verified
BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers
Khan, S., Wiegand, J., Zhang, P., Hu, W., Thummuri, D., Budamagunta, V., Hua, N., Jin, L., Allegra, C. J., Kopetz, S. E., et al. (2022) · Journal of Hematology & Oncology
Protein Degradation and InhibitorsCell death mechanisms and regulation
Cited by 62
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free